Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/28/2012 | US8124330 Screening methods for cognitive enhancers |
02/28/2012 | US8124121 Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
02/28/2012 | US8124090 Anti-factor D antibodies and methods of treatment |
02/28/2012 | US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders |
02/28/2012 | US8124067 Method for immunotherapy of tumors |
02/28/2012 | US8124066 Methods of using interleukin-2 mutants with reduced toxicity |
02/28/2012 | US8124052 for drug screening antitumor angents; genetic engineering; microarrays; kits |
02/28/2012 | US8124032 Microfluidic device and method of using same |
02/28/2012 | US8123929 Small volume in vitro analyte sensor |
02/28/2012 | US8123923 Film-type solid polymer ionomer sensor and sensor cell |
02/28/2012 | US8123920 Method and apparatus for assay of electrochemical properties |
02/28/2012 | US8123065 Container with lid |
02/28/2012 | US8122780 Explosion proof vehicle for tank inspection |
02/28/2012 | US8122757 Propellant ignition testing apparatus having a compressively sealable chamber |
02/28/2012 | US8122756 Narcotics and explosives particle removal system |
02/28/2012 | US8122711 Procedure to acquire a sooty particle concentration in the exhaust gas of an internal combustion engine |
02/28/2012 | CA2607102C Wood knot detecting method, device, and program |
02/28/2012 | CA2511175C Body fluid testing device |
02/28/2012 | CA2427542C Minimal procedure analyte test system |
02/28/2012 | CA2425775C Method and device for the manipulation of microcarriers for an identification purpose |
02/28/2012 | CA2397067C Cell isolation method |
02/28/2012 | CA2339901C Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences |
02/28/2012 | CA2333951C Method for treating neurodegenerative disorders |
02/28/2012 | CA2289652C Methods of enhancing functioning of the upper gastrointestinal tract |
02/28/2012 | CA2219361C Human antibodies derived from immunized xenomice |
02/24/2012 | DE202012000945U1 Testbesteck und Testreagenz zum Nachweis von Fibrinmonomeren Test kit and test reagent for the detection of fibrin monomers |
02/23/2012 | WO2012024695A1 Magnetic beads having surface glycoconjugates and use thereof |
02/23/2012 | WO2012024693A1 Density-based separation of biological analytes using multiphase systems |
02/23/2012 | WO2012024691A1 Multiphase systems for analysis of solid materials |
02/23/2012 | WO2012024690A1 Multiphase systems having multiple phase properties |
02/23/2012 | WO2012024688A1 Multiphase systems and uses thereof |
02/23/2012 | WO2012024643A2 MST1/STK4 PHOSPHO-THREONINE 120 (pMST-T120) ANTIBODY |
02/23/2012 | WO2012024640A2 Mst1 as a prognostic biomarker and therapeutic target in human cancer |
02/23/2012 | WO2012024623A2 Sox9 as a marker for aggressive cancer |
02/23/2012 | WO2012024619A2 Animal scent detection apparatus and system |
02/23/2012 | WO2012024612A1 Cancer diagnostic and cancer therapeutic |
02/23/2012 | WO2012024592A2 Compositions, methods, and systems comprising fluorous-soluble polymers |
02/23/2012 | WO2012024574A2 Small molecule arrays and methods for making and using them |
02/23/2012 | WO2012024546A2 Incorporation of health measurments in analysis and interpretation of functional biological response data |
02/23/2012 | WO2012024543A1 Circulating biomarkers for disease |
02/23/2012 | WO2012024439A2 Method and apparatus for electrocatalytic amplification on pre-oxidized measuring electrode |
02/23/2012 | WO2012024416A1 Assay for analytes using multiple receptors |
02/23/2012 | WO2012024255A2 Camkk-beta as a target for treating cancer |
02/23/2012 | WO2012024236A1 LTβR BLOCKADE: METHODS FOR OPTIMIZING THERAPEUTIC RESPONSIVENESS OF PATIENTS |
02/23/2012 | WO2012024234A1 Compositions and methods for inducing cancer cell death |
02/23/2012 | WO2012024194A2 Microfluidic cell separation in the assay of blood |
02/23/2012 | WO2012023852A1 A novel method for diagnosing q-fever using a cellular immunological test |
02/23/2012 | WO2012023845A1 Methods and means for characterizing antibiotic resistance in microorganisms |
02/23/2012 | WO2012023675A1 Modified nucleotides and real-time polymerase reaction using same |
02/23/2012 | WO2012023622A1 Reagent for tumor testing and pharmaceutical composition for tumor prevention |
02/23/2012 | WO2012023590A1 Method for quantitative measurement of gastric acidity using 13c carbonate salt |
02/23/2012 | WO2012023562A1 Method for evaluating graft |
02/23/2012 | WO2012023487A1 Metal complex, fluorescent probe |
02/23/2012 | WO2012023391A1 Spfs sensor equipped with non-specific adsorption type purification mechanism |
02/23/2012 | WO2012023345A1 Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom |
02/23/2012 | WO2012023298A1 Method for collection of nucleated red blood cells by density-gradient centrifugation utilizing change in density of blood cells |
02/23/2012 | WO2012023290A1 Rasef as tumor marker and therapeutic target for cancer |
02/23/2012 | WO2012023288A1 Fam161a as a target gene for cancer therapy and diagnosis |
02/23/2012 | WO2012023287A1 Suv420h1 and suv420h2 as target genes for cancer therapy and diagnosis |
02/23/2012 | WO2012023286A1 Lrrc42 as a target gene for cancer therapy and diagnosis |
02/23/2012 | WO2012023285A1 Ehmt2 as a target gene for cancer therapy and diagnosis |
02/23/2012 | WO2012023284A1 Lhx4 as a target gene for cancer therapy and diagnosis |
02/23/2012 | WO2012023259A1 C6orf167 as a target gene for cancer therapy and diagnosis |
02/23/2012 | WO2012023112A2 Bard1 isoforms in lung and colorectal cancer and use thereof |
02/23/2012 | WO2012023071A2 Dehydration sensors with ion-responsive and charged polymeric surfactants |
02/23/2012 | WO2012023070A2 Dehydration sensors having buffered inks |
02/23/2012 | WO2012022975A1 Identification of ligands and their use |
02/23/2012 | WO2012022948A1 Treatment of liver cancer |
02/23/2012 | WO2012022945A1 In-situ reagent for detection of proteins |
02/23/2012 | WO2012022885A1 Method for determining physical characteristics of nanoparticles or agglomerates of nanoparticles, and device for implementing such a method |
02/23/2012 | WO2012022809A1 Expandable enclosure for oil-in-water analysers |
02/23/2012 | WO2012022774A1 An assay for measurement of antibodies binding to a therapeutic monoclonal antibody |
02/23/2012 | WO2012022734A2 Anti-icam-1 antibodies and methods of use |
02/23/2012 | WO2012022728A2 Novel biosensors and their use |
02/23/2012 | WO2012022727A1 Lov-domain protein for photosensitive defunctionalization |
02/23/2012 | WO2012022682A1 Anti-human igg1 antibody |
02/23/2012 | WO2012022486A1 In vivo imaging of calcified lesions |
02/23/2012 | WO2012022459A1 Methods and means for diagnosing spondylarthritis using autoantibody markers |
02/23/2012 | WO2012022428A1 Method for isolating urea while removing objectionable co2 |
02/23/2012 | WO2012022243A1 Kit for quantitatively detecting her2 amplification |
02/23/2012 | WO2012022119A1 Multiassay immunochromatographic chip |
02/23/2012 | WO2012021969A1 Markers of the male urogenital tract |
02/23/2012 | WO2012021944A1 Methods and kits for predicting the onset of labour |
02/23/2012 | WO2012021942A1 Tam receptors and tam receptor ligands in detection and modulation of neuropathological disease |
02/23/2012 | WO2012001179A3 Linear ige peptide epitopes of hazelnut allergen cor a 1 and celery antigen api 1 |
02/23/2012 | WO2011160827A3 Novel jnk inhibitor molecules |
02/23/2012 | WO2011155859A3 Polysaccharide and derivatives thereof, showing affinity to ficolin-3, method of preparation and use |
02/23/2012 | WO2011153649A4 Device for determining features of a yarn |
02/23/2012 | WO2011146749A3 Testing method and kit for detecting lead, mercury and chromate in paint, varnish and other surface coatings |
02/23/2012 | WO2011143072A3 Method and apparatus for determining the coke generation tendency of hydrocarbons |
02/23/2012 | WO2011140182A3 Optimized degenerative muscle disease diagnostics and treatments |
02/23/2012 | WO2011133670A3 Biomedical and chemical sensing with nanobeam photonic crystal cavities using optical bistability |
02/23/2012 | WO2011133432A3 Methods to detect and isolate cancer stem cells |
02/23/2012 | WO2011130644A3 Phosphorylated nf45 biomarkers, antibodies and methods of using same |
02/23/2012 | WO2011130152A3 Method for identifying hla complexes associated with adverse drug reactions |
02/23/2012 | WO2011127386A3 Improved thermal uniformity for thermal cycler instrumentation using dynamic control |
02/23/2012 | WO2011127170A3 Methods for diagnosing and treating asthma |
02/23/2012 | WO2011127001A3 Quantum dot-based optical sensors for rapid detection and quantitative analysis of biomolecules and biological materials |
02/23/2012 | WO2011126892A3 Droplet operations platform |
02/23/2012 | WO2011120048A3 Nanomotors and motion-based detection of biomolecular interactions |